The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Cardiac Pacemaker-Global Market Insights and Sales Trends 2024
Synopsis
Artificial pacemakers are electronic devices used primarily to control cardiac rate in patients in whom the intrinsic heart rate is inadequate for a normal life style.
The global Artificial Cardiac Pacemaker market size is expected to reach US$ 21270 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Cardiac Pacemaker in various end use industries. The expanding demands from the Bradycardia, Tachycardia, Heart Failure and Other, are propelling Artificial Cardiac Pacemaker market. Pacemaker, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ICD segment is estimated at % CAGR for the next seven-year period.
With the increasing prevalence of cardiovascular diseases and the aging population, the demand for artificial cardiac pacemakers is on the rise. Factors such as technological advancements, the development of miniaturized devices, and improved patient outcomes are driving market growth. Key players in the market are investing in research and development to introduce innovative features and improve device performance. Additionally, favorable reimbursement policies and increasing awareness about cardiac health contribute to market expansion. However, challenges such as the high cost of devices and the risk of complications may hinder market growth. Overall, the Artificial Cardiac Pacemaker market is expected to witness significant growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Cardiac Pacemaker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Cardiac Pacemaker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Cardiac Pacemaker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Cardiac Pacemaker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Cardiac Pacemaker covered in this report include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix and Lepu, etc.
The global Artificial Cardiac Pacemaker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Abbott
Boston Scientific
Biotronik
LivaNova (Sorin)
Medico
IMZ
Pacetronix
Lepu
Global Artificial Cardiac Pacemaker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Cardiac Pacemaker market, Segment by Type:
Pacemaker
ICD
BI-V ICD
Global Artificial Cardiac Pacemaker market, by Application
Bradycardia
Tachycardia
Heart Failure
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Cardiac Pacemaker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Cardiac Pacemaker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Artificial pacemakers are electronic devices used primarily to control cardiac rate in patients in whom the intrinsic heart rate is inadequate for a normal life style.
The global Artificial Cardiac Pacemaker market size is expected to reach US$ 21270 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Cardiac Pacemaker in various end use industries. The expanding demands from the Bradycardia, Tachycardia, Heart Failure and Other, are propelling Artificial Cardiac Pacemaker market. Pacemaker, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ICD segment is estimated at % CAGR for the next seven-year period.
With the increasing prevalence of cardiovascular diseases and the aging population, the demand for artificial cardiac pacemakers is on the rise. Factors such as technological advancements, the development of miniaturized devices, and improved patient outcomes are driving market growth. Key players in the market are investing in research and development to introduce innovative features and improve device performance. Additionally, favorable reimbursement policies and increasing awareness about cardiac health contribute to market expansion. However, challenges such as the high cost of devices and the risk of complications may hinder market growth. Overall, the Artificial Cardiac Pacemaker market is expected to witness significant growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Cardiac Pacemaker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Cardiac Pacemaker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Cardiac Pacemaker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Cardiac Pacemaker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Cardiac Pacemaker covered in this report include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix and Lepu, etc.
The global Artificial Cardiac Pacemaker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Abbott
Boston Scientific
Biotronik
LivaNova (Sorin)
Medico
IMZ
Pacetronix
Lepu
Global Artificial Cardiac Pacemaker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Cardiac Pacemaker market, Segment by Type:
Pacemaker
ICD
BI-V ICD
Global Artificial Cardiac Pacemaker market, by Application
Bradycardia
Tachycardia
Heart Failure
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Cardiac Pacemaker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Cardiac Pacemaker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Cardiac Pacemaker Market Overview
1.1 Artificial Cardiac Pacemaker Product Overview
1.2 Artificial Cardiac Pacemaker Market Segment by Type
1.2.1 Pacemaker
1.2.2 ICD
1.2.3 BI-V ICD
1.3 Global Artificial Cardiac Pacemaker Market Size by Type
1.3.1 Global Artificial Cardiac Pacemaker Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Cardiac Pacemaker Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Cardiac Pacemaker Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Cardiac Pacemaker Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Cardiac Pacemaker Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Cardiac Pacemaker Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Cardiac Pacemaker Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Cardiac Pacemaker Sales Breakdown by Type (2018-2023)
2 Global Artificial Cardiac Pacemaker Market Competition by Company
2.1 Global Top Players by Artificial Cardiac Pacemaker Sales (2018-2023)
2.2 Global Top Players by Artificial Cardiac Pacemaker Revenue (2018-2023)
2.3 Global Top Players by Artificial Cardiac Pacemaker Price (2018-2023)
2.4 Global Top Manufacturers Artificial Cardiac Pacemaker Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Cardiac Pacemaker Market Competitive Situation and Trends
2.5.1 Artificial Cardiac Pacemaker Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Cardiac Pacemaker Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Cardiac Pacemaker as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Cardiac Pacemaker Market
2.8 Key Manufacturers Artificial Cardiac Pacemaker Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Cardiac Pacemaker Status and Outlook by Region
3.1 Global Artificial Cardiac Pacemaker Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Cardiac Pacemaker Historic Market Size by Region
3.2.1 Global Artificial Cardiac Pacemaker Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Cardiac Pacemaker Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Cardiac Pacemaker Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Cardiac Pacemaker Forecasted Market Size by Region
3.3.1 Global Artificial Cardiac Pacemaker Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Cardiac Pacemaker Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Cardiac Pacemaker Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Cardiac Pacemaker by Application
4.1 Artificial Cardiac Pacemaker Market Segment by Application
4.1.1 Bradycardia
4.1.2 Tachycardia
4.1.3 Heart Failure
4.1.4 Other
4.2 Global Artificial Cardiac Pacemaker Market Size by Application
4.2.1 Global Artificial Cardiac Pacemaker Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Cardiac Pacemaker Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Cardiac Pacemaker Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Cardiac Pacemaker Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Cardiac Pacemaker Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Cardiac Pacemaker Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Cardiac Pacemaker Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Cardiac Pacemaker Sales Breakdown by Application (2018-2023)
5 North America Artificial Cardiac Pacemaker by Country
5.1 North America Artificial Cardiac Pacemaker Historic Market Size by Country
5.1.1 North America Artificial Cardiac Pacemaker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Cardiac Pacemaker Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Cardiac Pacemaker Sales in Value by Country (2018-2023)
5.2 North America Artificial Cardiac Pacemaker Forecasted Market Size by Country
5.2.1 North America Artificial Cardiac Pacemaker Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Cardiac Pacemaker Sales in Value by Country (2024-2029)
6 Europe Artificial Cardiac Pacemaker by Country
6.1 Europe Artificial Cardiac Pacemaker Historic Market Size by Country
6.1.1 Europe Artificial Cardiac Pacemaker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Cardiac Pacemaker Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Cardiac Pacemaker Sales in Value by Country (2018-2023)
6.2 Europe Artificial Cardiac Pacemaker Forecasted Market Size by Country
6.2.1 Europe Artificial Cardiac Pacemaker Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Cardiac Pacemaker Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Cardiac Pacemaker by Region
7.1 Asia-Pacific Artificial Cardiac Pacemaker Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Cardiac Pacemaker Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Cardiac Pacemaker Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Cardiac Pacemaker Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Cardiac Pacemaker Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Cardiac Pacemaker Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Cardiac Pacemaker Sales in Value by Region (2024-2029)
8 Latin America Artificial Cardiac Pacemaker by Country
8.1 Latin America Artificial Cardiac Pacemaker Historic Market Size by Country
8.1.1 Latin America Artificial Cardiac Pacemaker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Cardiac Pacemaker Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Cardiac Pacemaker Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Cardiac Pacemaker Forecasted Market Size by Country
8.2.1 Latin America Artificial Cardiac Pacemaker Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Cardiac Pacemaker Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Cardiac Pacemaker by Country
9.1 Middle East and Africa Artificial Cardiac Pacemaker Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Cardiac Pacemaker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Cardiac Pacemaker Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Cardiac Pacemaker Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Cardiac Pacemaker Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Cardiac Pacemaker Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Cardiac Pacemaker Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Artificial Cardiac Pacemaker Products Offered
10.1.5 Medtronic Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Artificial Cardiac Pacemaker Products Offered
10.2.5 Abbott Recent Development
10.3 Boston Scientific
10.3.1 Boston Scientific Company Information
10.3.2 Boston Scientific Introduction and Business Overview
10.3.3 Boston Scientific Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boston Scientific Artificial Cardiac Pacemaker Products Offered
10.3.5 Boston Scientific Recent Development
10.4 Biotronik
10.4.1 Biotronik Company Information
10.4.2 Biotronik Introduction and Business Overview
10.4.3 Biotronik Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biotronik Artificial Cardiac Pacemaker Products Offered
10.4.5 Biotronik Recent Development
10.5 LivaNova (Sorin)
10.5.1 LivaNova (Sorin) Company Information
10.5.2 LivaNova (Sorin) Introduction and Business Overview
10.5.3 LivaNova (Sorin) Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.5.4 LivaNova (Sorin) Artificial Cardiac Pacemaker Products Offered
10.5.5 LivaNova (Sorin) Recent Development
10.6 Medico
10.6.1 Medico Company Information
10.6.2 Medico Introduction and Business Overview
10.6.3 Medico Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Medico Artificial Cardiac Pacemaker Products Offered
10.6.5 Medico Recent Development
10.7 IMZ
10.7.1 IMZ Company Information
10.7.2 IMZ Introduction and Business Overview
10.7.3 IMZ Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.7.4 IMZ Artificial Cardiac Pacemaker Products Offered
10.7.5 IMZ Recent Development
10.8 Pacetronix
10.8.1 Pacetronix Company Information
10.8.2 Pacetronix Introduction and Business Overview
10.8.3 Pacetronix Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pacetronix Artificial Cardiac Pacemaker Products Offered
10.8.5 Pacetronix Recent Development
10.9 Lepu
10.9.1 Lepu Company Information
10.9.2 Lepu Introduction and Business Overview
10.9.3 Lepu Artificial Cardiac Pacemaker Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Lepu Artificial Cardiac Pacemaker Products Offered
10.9.5 Lepu Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Cardiac Pacemaker Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Cardiac Pacemaker Industrial Chain Analysis
11.4 Artificial Cardiac Pacemaker Market Dynamics
11.4.1 Artificial Cardiac Pacemaker Industry Trends
11.4.2 Artificial Cardiac Pacemaker Market Drivers
11.4.3 Artificial Cardiac Pacemaker Market Challenges
11.4.4 Artificial Cardiac Pacemaker Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Cardiac Pacemaker Distributors
12.3 Artificial Cardiac Pacemaker Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
